SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,448.86 -260.83
( -0.35%)

Global Indices

Nasdaq

52,880.09 363.21
(0.69%)

Dow Jones

7,780.08 46.51
(0.60%)

Hang Seng

64,728.80 653.38
(1.02%)

Nikkei 225

10,751.68 18.68
(0.17%)

Forex

USD-INR

94.82 -0.08
(-0.09%)

EUR-INR

106.45 0.01
(0.01%)

GBP-INR

126.63 0.25
(0.20%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

285.6722314

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

19.64

15492.12

EPS(TTM)

Face Value()

Div & Yield %

40.14

1.52

Back

Aqylon Nexus reports standalone net profit of Rs 4.26 crore in the June 2026 quarter

Aug 08,2026

Net profit of Aqylon Nexus reported to Rs 4.26 crore in the quarter ended June 2026 as against net loss of Rs 1.84 crore during the previous quarter ended June 2025. Sales rose 28133.33% to Rs 8.47 crore in the quarter ended June 2026 as against Rs 0.03 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8.47	0.03	28133
OPM %	58.09	-2300.00	-
PBDT	4.54	-1.80	LP
PBT	4.26	-1.84	LP
NP	4.26	-1.84	LP

73,448.86 -260.83 ( -0.35%)

52,880.09 363.21 (0.69%)

7,780.08 46.51 (0.60%)

64,728.80 653.38 (1.02%)

10,751.68 18.68 (0.17%)

94.82 -0.08 (-0.09%)

106.45 0.01 (0.01%)

126.63 0.25 (0.20%)

0.60 0.00 (-0.04%)